| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/25/2012 | EP1080111B1 The induction of antiobiotic peptides by lait (scd14) protein |
| 07/25/2012 | EP0800829B2 Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin |
| 07/25/2012 | CN102612524A Dual variable domain immunoglobulins and uses thereof |
| 07/25/2012 | CN102612373A Therapeutic agent for gastrointestinal diseases |
| 07/25/2012 | CN102612369A Anti-tumor effect potentiator |
| 07/25/2012 | CN102600241A Traditional Chinese medicinal composition containing Kadsura longipedunculata and application of the composition |
| 07/25/2012 | CN102600216A Method for extracting plant polyphenol from Chinese chestnut involucre |
| 07/25/2012 | CN102600104A Chewable soft capsule |
| 07/25/2012 | CN102178840B Chinese medicinal preparation for relieving body fluid deficiency for people with yin-deficiency physique, preparation method thereof and application thereof |
| 07/25/2012 | CN102166315B Traditional Chinese medicine preparation for people with damp heat constitution to remove and resolve humidity, preparation method thereof and application thereof |
| 07/25/2012 | CN102038673B Application of hydroxyl benzopyrone compound for preparing medicament for treating leukemia |
| 07/25/2012 | CN101804199B Pharmaceutical composition used for alimentary canals and application thereof |
| 07/25/2012 | CN101693016B Universal pharmaceutical formulation for recombined human serum albumin fusion proteins for injection |
| 07/25/2012 | CN101678037B Combined use of cholestanol derivative |
| 07/25/2012 | CN101664489B Preparation method of traditional Chinese medical composition as well as quality control method thereof |
| 07/25/2012 | CN101600426B Isosorbide mononitrate derivatives for the treatment of intestinal disorders |
| 07/24/2012 | US8227620 Pharmaceutical compounds |
| 07/24/2012 | US8227570 Modified gherlin peptides |
| 07/24/2012 | US8227496 Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 07/24/2012 | US8227484 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 07/24/2012 | US8227474 Sodium channel blockers |
| 07/24/2012 | US8227471 Treating sexual desire disorders with flibanserin |
| 07/24/2012 | US8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D) |
| 07/24/2012 | US8227404 Method of preventing acute or sub-acute hepatic failure in a subject by administering a soluble human tumor necrosis factor alpha fusion protein |
| 07/24/2012 | US8227245 Multipotent stem cells from peripheral tissues and uses thereof |
| 07/24/2012 | US8227200 Methods for identifying kremen polypeptide binding partners |
| 07/24/2012 | US8226935 ErbB2 and ErbB3 chimeric heteromultimer receptors |
| 07/24/2012 | CA2690226C Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 07/24/2012 | CA2547625C Crystals of phenylalanine derivatives and production methods thereof |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/24/2012 | CA2471822C Cell-specific herpes simplex virus expression/replication vector comprising icp4 and human calponin gene promoter |
| 07/24/2012 | CA2438334C Ocular tear growth factor-like protein |
| 07/24/2012 | CA2412172C 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 07/24/2012 | CA2339411C Engraftable human neural stem cells |
| 07/19/2012 | WO2012097281A2 Injectable filler for podiatric and orthopedic uses |
| 07/19/2012 | WO2012095836A1 Anti-angiogenic compound |
| 07/19/2012 | WO2012095281A1 Amino acid composition and its use for treating intrauterine foetal growth restriction (iugr) or for parenteral nutrition of extremely pre-term infants |
| 07/19/2012 | WO2012094949A1 Use of etomidate in preparation of drug for preventing or treating posttraumatic stress disorder |
| 07/19/2012 | US20120184622 Composition for the treatment of cystic fibrosis |
| 07/19/2012 | US20120184599 Use of MicroRNA for Treating Diseases Associated with a Dysfunction of the Cilia in Multiciliated Epithelial Cells |
| 07/19/2012 | US20120184583 Modulators of atp-binding cassette transporters |
| 07/19/2012 | US20120184548 Carboxylic acid aryl amides |
| 07/19/2012 | US20120184533 Small molecule inhibitors of parp activity |
| 07/19/2012 | US20120184521 Substituted amide compound |
| 07/19/2012 | US20120183615 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone |
| 07/19/2012 | US20120183585 Gel based wound dressing and a method of synthesizing the same |
| 07/19/2012 | US20120183543 Diagnostic biomarkers for fibrotic disorders |
| 07/19/2012 | US20120183534 Methods, compositions and apparatuses for facilitating regeneration |
| 07/19/2012 | US20120183502 Combination therapy for lysosomal storage diseases |
| 07/19/2012 | US20120183493 Novel polymers |
| 07/18/2012 | EP2476747A1 Lactic acid bacteria having action of lowering blood uric acid level |
| 07/18/2012 | EP2476682A1 8-oxodihydropurine derivative |
| 07/18/2012 | EP2476678A1 Substituted carbonyl compounds |
| 07/18/2012 | EP2476668A1 Aniline compounds |
| 07/18/2012 | EP2476442A1 Root canal filler for non-extracted tooth and non-extraction method for regenerating dental tissue |
| 07/18/2012 | EP2476429A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units |
| 07/18/2012 | EP2475387A1 Use of vap-1 inhibitors for treating fibrotic conditions |
| 07/18/2012 | EP2475369A1 Use of steroid compounds for inflammatory and autoimmune disorders |
| 07/18/2012 | EP1893649B1 Method for the potentiation of opioid analgesics effects on pain |
| 07/18/2012 | EP1829542B1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same |
| 07/18/2012 | EP1470148B1 Double-stranded oligonucleotides |
| 07/18/2012 | EP1437961B1 Methods of suppressing microglial activation |
| 07/18/2012 | EP1435999B1 Combination of two bioactive regions of pro-opiomelanocortin hormone |
| 07/18/2012 | CN1753886B Process for producing acid adduct salt of polyacidic base compound |
| 07/18/2012 | CN1738636B Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states |
| 07/18/2012 | CN1639130B Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/18/2012 | CN1531533B Crystalline form of omeprazole |
| 07/18/2012 | CN1449445B Ev-vegf nucleic acids and polypeptides and methods of use |
| 07/18/2012 | CN1443167B Azacyclic compounds for use in treatment of 5-serotonin related diseases |
| 07/18/2012 | CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 07/18/2012 | CN102597778A Method for determination of sensitivity to anti-cancer ag |
| 07/18/2012 | CN102597762A Anticancer agent sensitivity-determining marker |
| 07/18/2012 | CN102596949A 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 07/18/2012 | CN102596935A Compounds useful for treating premature aging and in particular progeria |
| 07/18/2012 | CN102596270A Root canal filler for non-extracted tooth and non-extraction method for regenerating dental tissue |
| 07/18/2012 | CN102596256A Composition for treatment of pancreatic cancer |
| 07/18/2012 | CN102586276A 通过操作信使rna前体加工而提供的针对环境毒性的保护 By operating messenger rna precursor processing and provides protection against environmental toxicity |
| 07/18/2012 | CN102586006A Method for deeply developing and comprehensively utilizing medicinal and edible plant sea buckthorn |
| 07/18/2012 | CN102584685A Aryl compounds as PPAR ligands and their use |
| 07/18/2012 | CN102580066A Combination therapy for treating protein deficiency disorders |
| 07/18/2012 | CN102580043A Liquid for leading breeder cocks to be gregarious |
| 07/18/2012 | CN102579723A Chinese medicine preparation method for treating pus ears |
| 07/18/2012 | CN102579681A Pure Chinese medicinal composition for improving egg yolk color and preparation method thereof |
| 07/18/2012 | CN102579609A Blood-clearing dropping pills and preparation method thereof |
| 07/18/2012 | CN102579570A External ointment for treating itching pain and mosquito bite, refreshing brain and preventing sunstroke and dizziness |
| 07/18/2012 | CN102579535A Novel use of processed ginseng |
| 07/18/2012 | CN102198082B Micelle loaded with Tacrolimus or pharmaceutical salts thereof, lyophilized preparation as well as preparation methods and applications |
| 07/18/2012 | CN101926776B Salinomycin sodium suspension as well as preparation method and application thereof |
| 07/18/2012 | CN101880283B Azaindole kinase inhibitors |
| 07/18/2012 | CN101653581B Traditional Chinese medicine compound preparation for treating ptyalism of horses |
| 07/18/2012 | CN101490012B Novel crystal of substituted phenylalkanoic acid and production process |
| 07/18/2012 | CN101296914B Derivative having PPAR agonistic activity |
| 07/18/2012 | CN101277687B Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 07/18/2012 | CN101181351B Chinese medicine composition for resisting tiredness and reinforcing immune as well as method of making the same |
| 07/18/2012 | CN101048160B Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
| 07/18/2012 | CN101028098B Food composition containing bone collagen peptide |
| 07/17/2012 | US8222405 Phenylalanine derivatives |
| 07/17/2012 | US8222393 Using U7 polypeptide as diagnostic and therapeutic tool preventing and treating cell proliferative disorders |
| 07/17/2012 | US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids |
| 07/17/2012 | US8222381 Derivatives of monosaccharides for drug discovery |